{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:36:59Z","timestamp":1788953819627,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejca.2017.05.030","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T09:17:56Z","timestamp":1498123076000},"page":"6-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy"],"prefix":"10.1016","volume":"82","author":[{"given":"Ze-Ming","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Pan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Sheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.05.030_bib1","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2017.05.030_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","article-title":"Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years","volume":"2","author":"Rosen","year":"1978","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2017.05.030_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0277-5379(91)90055-I","article-title":"Risk of invasive cancer in women with lobular carcinoma in situ of the breast","volume":"27","author":"Salvadori","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.05.030_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","article-title":"Lobular neoplasia. Long term risk of breast cancer and relation to other factors","volume":"78","author":"Bodian","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.05.030_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.11883","article-title":"Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ","volume":"100","author":"Fisher","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.05.030_bib6","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.05.030_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1308\/rcsann.2015.0037","article-title":"UK national survey of management of breast lobular carcinoma in situ","volume":"97","author":"Chester","year":"2015","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.ejca.2017.05.030_bib8","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, et\u00a0al. NCCN clinical practice guidelines in oncology: breast cancer. Version 2.2016. Available at: NCCN.org. [Accessed 9 November 2016]."},{"key":"10.1016\/j.ejca.2017.05.030_bib9","unstructured":"Bevers TB, Ward JH, Aran BK, et\u00a0al. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction. Version 1.2016. Available at: NCCN.org. [Accessed 9 November 2016]."},{"key":"10.1016\/j.ejca.2017.05.030_bib10","first-page":"428","article-title":"Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome","volume":"56","author":"Bradley","year":"1990","journal-title":"Am Surg"},{"key":"10.1016\/j.ejca.2017.05.030_bib11","unstructured":"Software: Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov\/seerstat) version 8.3.2."},{"key":"10.1016\/j.ejca.2017.05.030_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1019950918046","article-title":"Changing incidence of lobular carcinoma in situ of the breast","volume":"75","author":"Li","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2017.05.030_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.05.030_bib14","first-page":"519","article-title":"Lobular carcinoma in situ. A long-term follow-up in 52 cases","volume":"82","author":"Andersen","year":"1974","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"10.1016\/j.ejca.2017.05.030_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00000478-199301000-00002","article-title":"Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group","volume":"17","author":"Ottesen","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2017.05.030_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2017.05.030_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2017.05.030_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/PAI.0000000000000254","article-title":"Prognostic value of coexisting lobular carcinoma in situ with invasive lobular carcinoma","volume":"24","author":"Harbhajanka","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ejca.2017.05.030_bib19","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2015.60.8133","article-title":"Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial","volume":"33","author":"Metzger Filho","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.05.030_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1008340723974","article-title":"Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome","volume":"11","author":"Foulkes","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.05.030_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-010-0859-2","article-title":"Effect of BRCA1\/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis","volume":"122","author":"Lee","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2017.05.030_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1078-0432.CCR-14-1816","article-title":"Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis","volume":"21","author":"Zhong","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2017.05.030_bib23","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.05.030_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/TACG.S35605","article-title":"Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors","volume":"6","author":"Evans","year":"2013","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.ejca.2017.05.030_bib25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.05.030_bib26","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2017.05.030_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.05.030_bib28","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejca.2017.05.030_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejca.2017.05.030_bib30","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2017.05.030_bib31","first-page":"108","article-title":"Breast cancer chemoprevention: a network meta-analysis of randomized controlled trials","author":"Mocellin","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.05.030_bib32","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.14694\/EdBook_AM.2015.35.e50","article-title":"Addressing barriers to uptake of breast cancer chemoprevention for patients and providers","author":"Crew","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejca.2017.05.030_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.6004\/jnccn.2015.0052","article-title":"Breast cancer risk reduction therapy: the low-hanging fruit","volume":"13","author":"Bevers","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.ejca.2017.05.030_bib34","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.3892\/ol.2016.5331","article-title":"Pleomorphic lobular carcinoma in situ: current evidence and a systemic review","volume":"12","author":"Wazir","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2017.05.030_bib35","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917309942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917309942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T14:28:04Z","timestamp":1569508084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917309942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":35,"alternative-id":["S0959804917309942"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.05.030","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}